Company Filing History:
1 out of 647 
1 out of 832,843 Years Active: 2010-2021
Title: Kim M Keeling: Innovator in Genetic Therapies
Introduction
Kim M Keeling is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of genetic therapies, particularly in the treatment of diseases associated with premature termination mutations. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Kim M Keeling's latest patents include innovative methods and compounds for stimulating read-through of premature termination codons. The first patent provides compositions and methods for treating and preventing diseases and conditions associated with premature termination mutations. This method involves administering a therapeutically effective dose of a compound that induces read-through of the premature termination codon. Additionally, it may include enzyme replacement therapy tailored to the specific disease or condition being treated.
Her second patent focuses on aminoglycoside treatment for lysosomal storage diseases, such as Hurler syndrome and Batten disease. This invention outlines a method of treating these conditions by administering a therapeutically effective dose of an aminoglycoside. Similar to her first patent, this method may also involve enzyme replacement therapy and pharmacological suppression of premature stop mutations in affected individuals.
Career Highlights
Throughout her career, Kim has worked with the UAB Research Foundation, where she has been able to further her research and innovations. Her work has garnered attention in the scientific community, showcasing her dedication to advancing medical treatments.
Collaborations
Kim M Keeling has collaborated with notable individuals in her field, including David M Bedwell and Steven Mark Rowe. These collaborations have likely contributed to the success and development of her innovative patents.
Conclusion
Kim M Keeling is a trailblazer in the realm of genetic therapies, with her patents paving the way for new treatment options for serious genetic conditions. Her contributions to science and medicine are invaluable and continue to inspire future innovations.